A bill that sought to put a state cap on the price of insulin, and require rebates from drug companies, has been dropped by its sponsor. State Senator Yvanna Cancela says she’s been advised by legislative legal counsel, the bill could violate federal interstate commerce laws. She is still purshing for other reforms, including detailed disclosure rules about drug prices, and the lobbying and political donations behind them.